Long-Term Care

The FDA approved an extended-release opioid

MDS 3.0 Insider, November 21, 2014

Want to receive articles like this one in your inbox? Subscribe to MDS 3.0 Insider!

 The U.S. Food and Drug Administration gave market clearance to an extended-release opioid, designed for those with severe pain, yesterday. The medication is likely to be an option for long-term care residents in severe pain.

  To continue reading, visit our blog MDSCentral.



Want to receive articles like this one in your inbox? Subscribe to MDS 3.0 Insider!

Most Popular